Resources for Neuropharmacists
All
- All
- Audit and Project Information
- Brain Health
- Collaborating with industry partners
- DMTS
- Job description for team members
- Medication
- Population health
- Pregnancy
- Protocols and pathways
- recent publications
- Service Development
- TMS For All Summit 2023
MS Journal: A comparison of JC virus assay performance provided with originator and biosimilar natalizumab
MS and Related disorders: Approach to JCV testing with natalizumab biosimilar: a UK consensus statement
Nature Reviews: Autologous haematopoietic stem cell transplantation for treatment of MS and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT
Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus
Abstract Background Multiple sclerosis (MS) is frequently diagnosed in people of reproductive age, many of whom will become pregnant following diagnosis. Although many women report an improvement in symptoms and relapses during pregnancy, symptoms such as fatigue and spasticity are commonly reported and can worsen. Prescribing medications during pregnancy and breastfeeding presents unique challenges and…
